Effects of unani formulation in wound healing

Efficacy and Safety Evaluation of Marham-e-Raal and Qurs-e- Asfar in dermatosurgical outcome and wound healing: A Randomized Controlled Trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063110

Enrollment

Registered

2024-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

Intervention1: Marham-e-Raal and Qurs-e-asfar: GROUP A (Test group) will be subjected to Marham-e-Raal dressing and Qurs-e-Asfar two tablets twice a day orally. Duration of intervention will be upto

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adults 18 years or older of all sex having drainable abscess less than or equal to 5cm in greater diameter 2 Adults having Corn of 3 to 7 mm in greater diameter.

Exclusion criteria

Exclusion criteria: Immunocompromising conditions Clinically diagnosed Tubercular abscess Severe anaemia Uncontrolled HTN HIV AIDS Patients who used Immunosuppressive therapy Carcinoma Known allergy to either test drugs Marhame Raal and Qurse Asfar or control drugs Povidone Iodine and Penicillin group and beta lactam group antibiotics

Design outcomes

Primary

Measure	Time frame
Clinical complete wound healing Timepoint: Base line, 2nd day, 4th day and 10th day	—

Secondary

Measure	Time frame
Discomfort on dressing change and Patient SatisfactionTimepoint: 2nd day and 4th day	—

Countries

India

Contacts

Public ContactDr Kausar

Hakim Syed Ziaul Hasan Government Autonomous Unani Medical College and Hospital

mohddr@gmail.com7828550209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026